Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Clinical trial NCT05464030 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05464030
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-04
- Primary completion
- 2026-10-23
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.